Cambridge Healthtech Institute’s 13th Annual

Enrollment Planning and Patient Recruitment  

Predicting and Improving Enrollment through Evidence, Data, New Tech and Creative Engagement

February 19-20, 2020


Patient recruitment and up-front enrollment planning are critical to drug development programs. Patient recruitment, if not adequately planned for, can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order to have complete data sets for your analysis and subsequent filings. To optimize both, you have to have a plan and effectively leverage analytics and technology without losing site of the participant’s user experience. One must take into account the needs of different patient populations, the importance of diversity, how to use digital tech, challenges of consent processes, direct-to-patient models, and many other factors. CHI’s 13th Annual “Enrollment Planning and Patient Recruitment” will cover the topics one should consider when drafting and strategically implementing a patient recruitment plan for a patient-centric and inclusive clinical development program.

Stay on and attend Part 2 (Thurs-Fri): Patient Engagement, Enrollment and Retention through Communities and Technology

Preliminary Agenda

PATIENTS, DATA, DIVERSITY, TECHNOLOGY: OPERATIONALIZING PATIENT-CENTRIC ENROLLMENT USING DIGITAL TECH AND DIRECT-TO-PATIENT MODELS

Data and Diversity: The Need for Increased Representation Across Clinical Trials

Charlotte Jones-Burton, MD, Cardiovascular Development Team Lead, Innovative Medicines, Bristol-Myers Squibb

The Intersection of Patients and Technology: Innovating Clinical Trials with Patients in Mind

Michelle Shogren, Director of Innovation, Pharma R&D Clinical Operations, Bayer

CASE STUDY: Operationalizing Patient-Centric Enrollment Using Digital Tech and Direct-to-Patient Models

Greg Hersch, Head, Innovation, Global Development Operations, Novartis

PROVEN METHODOLOGIES FOR CONNECTING PATIENTS WITH TRIALS & SUPPORTING RECRUITMENT AT PROGRAM AND STUDY LEVEL

Let’s Talk Options and Scalability: Exploring the Evolution of Patient-Centric Technologies in Clinical Trials

Hassan Kadhim, Director, Clinical Trial Business Capabilities, GCO, Bristol-Myers Squibb

Supporting Clinical Trial Recruitment: Program versus Study Level

Melanie Goodwin, Director, Patient Recruitment Programs, Clinical Development & Operations, Pfizer

IMPROVING ENROLLMENT UTILIZING AI/ANALYTICS & ENGAGING PATIENTS FOR DIGITAL HEALTH TRIALS

CASE STUDY: Democratizing Clinical Trials with AI to Solve the Patient Matching Problem

Pablo Graiver, Founder & CEO, Antidote.me

Engaging Patients in Digital Health Trials: Experiences from a Large Academic Health Center

Ramya Palacholla, MD, Lead Scientist, Partners HealthCare Pivot Labs

IMPROVING ENROLLMENT AND OUTCOMES FOR UNDERSERVED AND OTHER PATIENT POPULATIONS VOLUNTEERS BY LISTENING

CO-PRESENTATION: Listening to Representative Patient Populations Matters: How Co-creating with Patients Creates Better Outcomes

Cassandra Smith, MBA, Associate Director, Diversity and Inclusion in Clinical Trials Lead, Janssen
Lauren Gadsby, MBA, Program Manager, Investigator and Patient Engagement, Janssen

PRACTICAL DATA-DRIVEN APPROACHES TO PARTICIPANT RECRUITMENT & LEVERAGING RWD TO OPTIMIZE ELIGIBILITY CRITERIA

CO-PRESENTATION: Data-Driven Approach to Participant Recruitment

Charissa Barger, MS, Recruitment Specialist, Alzheimer's Therapeutic Research Institute, Keck School of Medicine, USC
Speaker to be Announced, Brain Health Registry, UCSF

How to Use RWD to Optimize Eligibility Criteria and Enhance Recruitment

Jack Sheehan, RPh, MBA, PhD, Director, Real-World Value and Evidence, Neuroscience, Janssen Scientific Affairs (JSA)

BRIDGING LUNCHEON PRESENTATION


 

PLENARY KEYNOTES

Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing: www.scopesummit.com/breakouts

 

Stay on and attend Part 2 (Thurs-Fri): Patient Engagement, Enrollment and Retention through Communities and Technology




For more details on the conference, please contact:
Micah Lieberman

Executive Director, Conferences

Cambridge Healthtech Institute (CHI)

Phone: (+1) 541. 482.4709
Email: mlieberman@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.5457

Email: iquigley@healthtech.com

 

Companies L-Z

Patty Rose
Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.1349
Email: prose@healthtech.com